SPDR S&P 500 ETF Trust (SPY)’s Big Bear: Is Soros Preparing for a Big Drop?

When George Soros takes a big position, everyone sits back and takes notice. The man who broke the Bank of England is known for not shying away from placing a big bet when he is convinced about something panning out exactly the way he foresees. One such trade that Soros has put up recently is a massive build up of a short position in SPDR S&P 500 ETF Trust (NYSEARCA:SPY), placed under Put options. Though it can be that Soros is hedging his exposure to the stocks he is long in, but whether that is true or not are just guesses.

George Soros

Kate Kelly  reported on the huge position taken by Soros on SPDR S&P 500 ETF Trust (SPY)’s Puts on CNBC, recently.

“Soros Fund Management, the family office that manages the assets of billionaire George Soros, has just disclosed a huge bearish position on the S&P500, suggesting that Soros may think that the market is in for a big drop. According to the recent filings Soros’ fund company holds puts in the SPDR S&P 500 ETF Trust (SPY), which tracks the S&P500, totalling 11.29 million at the end of the second quarter, that was the time when many fund managers were fighting nerves about the state of the stock market […],” Kelly said.

Kelly revealed that Soros Fund Management also has old positions built over the past few years  in the SPDR S&P 500 ETF Trust (SPY)’s Puts, but this recent position was by far the highest. Although it’s still not clear whether Soros still holds these Puts or not, but if he does, then the notional value of his SPDR S&P 500 ETF Trust (SPY)’s Put position comes at around $2.2 billion.

“[…] Still, it’s hard to read too much into the figure given that the SPDR S&P 500 ETF Trust (SPY) Put is a popular hedge and that Soros is long quite a few stocks as well. Positions that he may be trying to counterbalance, those of course include the Argentine oil company YPF, Teva Pharmaceutical, Tibco Software and a popular stock to talk about for us, which is Herbalife […],” Kelly added.

Disclosure: None

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!